Skip to main content

Month: April 2025

ParaZero Extends Class C5 Certification for SafeAir System to Additional DJI Mavic 3 Models

Expanded compliance now includes Mavic 3 Pro and Mavic 3 Pro Cine, completing Class C5 coverage across core M3 series models TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced an extension of its European regulatory compliance under Class C5 for its SafeAir™ system designed for DJI’s Mavic 3 drone series. Following the recent inclusion of the Mavic 3 Pro and Mavic 3 Pro Cine submodels, ParaZero’s SafeAir system now achieves full Class C5 conformity across the following DJI Mavic 3 platforms:Mavic 3 Enterprise (Mavic 3E) Mavic 3 Thermal (Mavic 3T) Mavic 3 Pro Mavic 3 Pro CineThis certification extension follows confirmation...

Continue reading

Spirit Digital AG Confirms Ticker Listings for Ethereum and Solana Yield+ ETPs on SIX and Deutsche Börse

Zug, Switzerland, April 10, 2025 (GLOBE NEWSWIRE) — Spirit Digital AG (“Spirit”), a wholly owned subsidiary of Spirit Blockchain Capital Inc. (CSE:SPIR / OTC:SPBCF / FRA:RTFB), helping advance digital asset finance through thoughtful innovation, is pleased to announce that its first suite of Exchange Traded Products (ETPs) — the Spirit Ethereum Yield+ ETP and Spirit Solana Yield+ ETP — now have confirmed and official ticker listings on both the SIX Swiss Exchange and Deutsche Börse Xetra. This follows the March 27 announcement of the product launch and represents a key milestone in the Company’s commitment to delivering institutional-grade access to staking rewards through transparent and regulated investment vehicles. The newly confirmed ticker symbols are as follows and will be available for trading on April 10, 2025. Official...

Continue reading

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed to serve as President of the Company. Heshmatpour will retain his role as Executive Chairman, while taking on day-to-day leadership responsibilities to accelerate the Company’s strategic and clinical initiatives. “Amir’s appointment as President reflects our commitment to strong, visionary leadership as NeOnc advances its clinical programs,” said Dr. Thomas Chen, CEO of NeOnc. “His extensive experience in building and scaling companies, coupled with his deep understanding of capital markets and business development, will be...

Continue reading

Bridger Aerospace Awarded Exclusive-Use Contract by State of Montana for Innovative Wildfire Detection Aircraft

BELGRADE, Mont., April 10, 2025 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”) (NASDAQ: BAER, BAERW), announced today that, after participating in a competitive bidding process, it has been notified by the State of Montana as the successful bidder for an exclusive-use contract to provide wildfire detection and mapping using a specially modified Daher Kodiak 100 aircraft. The exclusive-use agreement includes an initial one-year term, with two optional extension years pending continued state funding. The contract provides for a minimum of 120 days of availability for a minimum annual value of $648,000 with additional days and flight hours incremental to the minimum annual value. “With this award, nearly all of Bridger’s air attack and sensor-equipped fleet is either committed or currently...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 09 04 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – [Niox]

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Danske Bank A/S(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree NIOX Group plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites worldwide primarily in the US; topline data readout expected in Q2 2026 with NDA submission to follow Company to provide an update on the DIAMOND program and its innovative late-stage pipeline at the upcoming in-person and virtual R&D Day on Tuesday, April 15ZUG, Switzerland, April 10, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced that it has completed enrollment in both Phase 3 DIAMOND-1...

Continue reading

Eviden signs a 50-million-euro contract to build Serbia’s National AI Factory

Eviden will bring together a unique comprehensive set of AI capabilities – supercomputing power for AI, software layer and AI use-cases development Paris, France – April 10, 2025 – Eviden, the Atos Group business leading in digital, cloud, big data and security today announces the signature of a 50-million-euro contract with the Serbia’s Office for IT and eGovernment. Together, Eviden and the Serbian administration will deploy a National AI Factory – composed of an AI Center of Excellence and a leading AI-dedicated supercomputing platform – aiming to accelerate Serbia’s AI capabilities and foster innovation across key sectors while reinforcing its technological autonomy using European technologies. More than just a simple infrastructure, an AI Factory is an extensive and complete set of shared AI-dedicated assets – talents, expertise,...

Continue reading

Konsolidator enters partnership with Exsitec to accelerate growth in the Nordics

Press release no. 1-2025Copenhagen, April 10, 2025 Konsolidator enters partnership with Exsitec to accelerate growth in the Nordics Today, Konsolidator enters a new strategic partnership with Exsitec AB, one of the most prominent players in the Nordic region, to implement and manage business-supporting IT systems. The partnership allows Konsolidator to be fully partner-driven in Sweden and Norway, thereby significantly advancing the company’s 2025–2027 strategy, Resilient Growth, which prioritizes scaling growth through strategic partnerships. Exsitec, a long-standing customer of Konsolidator, brings in-depth product knowledge and integration experience. Furthermore, with shared customers and strong expertise in finance IT, Exsitec is an ideal partner for making Konsolidator available to more companies in the Nordics, especially in the...

Continue reading

STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost base

PR No: C3330C STMicroelectronics details company-wide program to reshape manufacturing footprint and resize global cost baseIncreasing efficiency, automation, and AI will strengthen ST’s key technology R&D, design and high-volume assets for advanced manufacturing in Europe.Planned investments over FY2025, 2026 and 2027 to focus on advanced manufacturing infrastructure in 300mm silicon, 200mm silicon carbide, and technology R&D, for the benefit of customers globally.Company-wide program, including both the previously disclosed resizing of cost base and the reshaping of manufacturing footprint, expected to see up to 2,800 people leaving the company globally on a voluntary basis over 3 years, on top of normal attrition.Confirmation of annual cost savings target in the high triple-digit million-dollar range exiting 2027.Geneva,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.